Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-200
Closed -$13K 150
2020
Q1
$13K Hold
200
0.02% 126
2019
Q4
$16K Hold
200
0.01% 167
2019
Q3
$15K Hold
200
0.01% 154
2019
Q2
$13K Hold
200
0.01% 168
2019
Q1
$10K Buy
+200
New +$9.63K 0.01% 171

Other funds holding NVCR

G&S Capital's NVCR Position: Q2 2020 in Review

G&S Capital sold out of NovoCure (NVCR) in Q2 2020, closing a stake of 200 shares — an estimated $13K sold.

G&S Capital first reported a position in NVCR in Q1 2019 and held it in 5 quarters. The position peaked at $16K in Q4 2019. 264 funds tracked by Wall St. Rank hold NVCR as of Q2 2020.

  • G&S Capital reported no remaining NovoCure position as of Q2 2020 after selling out during the quarter.
  • G&S Capital sold 200 NovoCure shares in Q2 2020, an estimated $13K.
  • G&S Capital first reported a position in NovoCure in Q1 2019 and held it in 5 quarters.
  • G&S Capital's NovoCure position peaked at $16K in Q4 2019.
  • 264 funds tracked by Wall St. Rank held NovoCure as of Q2 2020.

Based on G&S Capital's 13F filing for Q2 2020, filed 24 Jul 2020.